Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) Gross Margin (2019 - 2025)

Historic Gross Margin for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to 99.31%.

  • CureVac's Gross Margin rose 37500.0% to 99.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 93.28%, marking a year-over-year increase of 219700.0%. This contributed to the annual value of 80.23% for FY2024, which is 2115700.0% up from last year.
  • Latest data reveals that CureVac reported Gross Margin of 99.31% as of Q3 2025, which was up 37500.0% from 77.67% recorded in Q2 2025.
  • CureVac's Gross Margin's 5-year high stood at 99.31% during Q3 2025, with a 5-year trough of 583.77% in Q4 2022.
  • Over the past 5 years, CureVac's median Gross Margin value was 77.67% (recorded in 2025), while the average stood at 114.46%.
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 375497400bps in 2021, then tumbled by -5138200bps in 2022.
  • CureVac's Gross Margin (Quarter) stood at 69.95% in 2021, then plummeted by -735bps to 583.77% in 2022, then skyrocketed by 77bps to 137.15% in 2023, then soared by 165bps to 89.76% in 2024, then grew by 11bps to 99.31% in 2025.
  • Its Gross Margin stands at 99.31% for Q3 2025, versus 77.67% for Q2 2025 and 2.02% for Q1 2025.